Format

Send to

Choose Destination
J Palliat Med. 2012 May;15(5):548-54. doi: 10.1089/jpm.2011.0310. Epub 2012 Apr 2.

Association of age, gender, and race with intensity of end-of-life care for Medicare beneficiaries with cancer.

Author information

1
Maine Medical Center Research Institute, Maine Medical Center, Portland, Maine, USA. MIESFS@mmc.org

Abstract

PURPOSE:

To measure intensity of end-of-life (EOL) care for Medicare cancer patients and variations in care by age, gender, and race.

PATIENTS AND METHODS:

This retrospective cohort analysis of Medicare claims (20% sample) examined 235,821 Medicare Parts A and B fee-for-service patients dying with poor-prognosis cancers between 2003 and 2007. Logistic regression models quantified associations between care intensity and age, gender, and race. Measures included hospitalizations, emergency department (ED) visits, intensive care unit (ICU) admissions, in-hospital deaths, late-life chemotherapy administration, overall and late hospice enrollment within six months of death.

RESULTS:

Within 30 days of death, 61.3% of patients were hospitalized, 10.2% were hospitalized more than once, 10.2% visited an ED more than once, 23.7% had ICU admissions, and 28.8% died in-hospital. Within two weeks of death, 6% received chemotherapy. In their final six months, 55.2% accessed hospice, 15.1% within three days of death. Older age (≥75 versus <75) was associated with lower odds ratios (ORs) of 0.49 to 0.89 for aggressive care, and an OR of 0.92 (95% CI 0.89-0.95) for late hospice enrollment. Female gender was associated with lower ORs (0.82 to 0.86) for aggressive care, and an OR of 0.84 (95% CI 0.81-0.86) for late hospice enrollment. Black (versus nonblack) race was associated with higher ORs (1.08 to 1.38) for aggressive acute care, lower ORs for late chemotherapy, OR 0.76 (95% CI 0.71-0.81), and late hospice enrollment, OR 0.81 (95% CI 0.76-0.86).

CONCLUSIONS:

Seniors dying with poor-prognosis cancer experience high-intensity care with rates varying by age, gender, and race.

PMID:
22468739
PMCID:
PMC3353746
DOI:
10.1089/jpm.2011.0310
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center